Pricing Log in Create free account

Bio-Rad Laboratories, Inc. (BIO.B) vs Smith & Nephew SNATS, Inc. (SNN)

Bio-Rad Laboratories, Inc. and Smith & Nephew SNATS, Inc. are both Medical Devices companies. Smith & Nephew SNATS, Inc. is the larger, with a market value of $13.4B against $10.3B — 1.3× the size. Bio-Rad Laboratories, Inc. trades at the lower P/E: 9.9× against 38.9×. Smith & Nephew SNATS, Inc. grew revenue faster over the last twelve months: 4.81% against 1.38%. Bio-Rad Laboratories, Inc. has the higher net margin (39.5% vs 6.71%) and the lower return on invested capital (−0.44% vs 0.00%). Across the 21 metrics below, Bio-Rad Laboratories, Inc. leads on 11 and Smith & Nephew SNATS, Inc. on 10.

Valuation

Metric BIO.B SNN Medical Devices median
P/E 9.95 38.94 25.58
P/S 3.92 1.37 2.54
P/B 1.34 2.77 2.48
Price to free cash flow 30.74 7.09 28.81
EV/EBITDA n/m 6.54 11.51
EV/Sales 3.76 1.60 2.72
Earnings yield 10.06% 2.57% (12.82%)
Free cash flow yield 3.25% 14.10% (8.18%)

Profitability

Metric BIO.B SNN Medical Devices median
Gross margin 51.26% 70.52% 57.76%
Operating margin (2.39%) 0.00% (15.07%)
Net margin 39.45% 6.71% (14.45%)
Free cash flow margin 18.05% 0.00% (3.88%)
Return on equity 14.27% 0.00% (10.35%)
Return on assets 9.99% 0.00% (17.26%)
Return on invested capital (0.44%) 0.00% (5.27%)

Growth

Metric BIO.B SNN Medical Devices median
Revenue growth (TTM) 1.38% 4.81% 10.41%
EPS growth (last fiscal year) 142.61% 52.34% 28.17%
Revenue growth, 5-year CAGR 0.29% 6.21% 15.74%
Net income growth, 5-year CAGR (27.58%) 6.89% 0.00%

Health

Metric BIO.B SNN Medical Devices median
Debt to equity 0.16 0.62 0.04
Current ratio 3.18 2.14 2.74
Net debt to EBITDA (7.15) 1.92 0.54

Dividend

Metric BIO.B SNN Medical Devices median
Dividend yield — 2.49% 1.02%
Payout ratio — — 0.37

Size

Metric BIO.B SNN Medical Devices median
Market cap 10.33b 13.40b 239.53m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack